Evenity

Osteoporosis therapy with Evenity actually creates new bone unlike Fosamax or alendronate which simply retards further bone loss. Evenity inhibits the action of a naturally produced chemical sclerostin. Since sclerostin inhibits new bone growth and enhance bone dissolution, Evenity appears well suited to treat age related bone loss.

Evenity loses its effect after approximately one year. It may be prescribed as 12 monthly injections and must be followed by other treatment perhaps with Prolia or a bisphosphonate such as Fosamax, Actonel, Boniva or Reclast.

Unfortunately several studies demonstrated a rather alarming increase in the incidence of heart attack, stroke and cardiovascular related death related to Evenity. The label now carries a black box warning which creates confusion and dampens the potential commercial success of the drug.

The cash price for Evenity exceeds $1800 a month with roughly translates to $60+ each day.